Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jan;7(1):48-58.
doi: 10.1038/nrcardio.2009.198. Epub 2009 Nov 24.

Cardiovascular effects of relaxin: from basic science to clinical therapy

Affiliations
Review

Cardiovascular effects of relaxin: from basic science to clinical therapy

Xiao-Jun Du et al. Nat Rev Cardiol. 2010 Jan.

Abstract

Although substantial advances have been achieved in recent decades in the clinical management of heart diseases, new therapies that provide better or additional efficacy with minimal adverse effects are urgently required. Evidence that has accumulated since the 1990s indicates that the peptide hormone relaxin has multiple beneficial actions in the cardiovascular system under pathological conditions and, therefore, holds promise as a novel therapeutic intervention. Clinical trials for heart failure therapy using relaxin revealed several beneficial actions. Here we review findings from mechanistic and applied research in this field, comment on the outcomes of recent phase I/II clinical trails on patients with heart failure, and highlight settings of cardiovascular diseases where relaxin might be effective.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2384-8 - PubMed
    1. Nature. 1983 Feb 17-23;301(5901):628-31 - PubMed
    1. J Am Coll Cardiol. 2008 Feb 26;51(8):802-9 - PubMed
    1. Mol Endocrinol. 2003 Jun;17(6):1075-84 - PubMed
    1. Circulation. 2004 May 18;109(19):2266-8 - PubMed

LinkOut - more resources